taurocholic acid has been researched along with Diabetes Mellitus, Type 2 in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hui, S; Lang, H; Liu, Y; Mi, M; Wang, X; Yi, L; Zhou, M | 1 |
| Bae, YH; Byun, Y; Cho, KJ; Cho, S; Hwang, YH; Kang, SH; Lee, DY; Lee, M; Lee, SA; Lee, YK; Nurunnabi, M; Revuri, V | 1 |
| Bi, D; Cheng, Z; Hu, S; Liu, G; Zhang, X | 1 |
| Bell, CG; Bell, JT; Berdasco, M; Brosnan, MJ; Deloukas, P; Esteller, M; Ferreira, T; Gao, F; Hyde, CL; John, SL; Liu, Y; Loomis, AK; Lu, H; McCarthy, MI; Morris, AP; Small, KS; Spector, TD; Viñuela, A; Wang, J; Ward, KJ; Wu, H; Xia, Y; Yet, I; Yuan, W | 1 |
| Adrian, TE; Al Kaabi, J; Gariballa, S; Gedulin, B; Nagelkerke, N; Parekh, KA; Saadi, H; Thomas, SA; Young, AA | 1 |
| Bound, MJ; Gedulin, B; Horowitz, M; Jones, KL; Rayner, CK; Standfield, SD; Wu, T | 1 |
6 other study(ies) available for taurocholic acid and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Capsaicin Improves Glucose Tolerance and Insulin Sensitivity Through Modulation of the Gut Microbiota-Bile Acid-FXR Axis in Type 2 Diabetic db/db Mice.
Topics: Animals; Bile Acids and Salts; Capsaicin; Diabetes Mellitus, Type 2; Fibroblast Growth Factors; Gastrointestinal Microbiome; Glucose; Insulin Resistance; Male; Mice; Mice, Inbred C57BL; Receptors, Cytoplasmic and Nuclear; Signal Transduction; Taurocholic Acid | 2019 |
Oral delivery of a therapeutic gene encoding glucagon-like peptide 1 to treat high fat diet-induced diabetes.
Topics: Animals; Cell Line; Diabetes Mellitus, Type 2; Diet, High-Fat; DNA; Female; Gene Transfer Techniques; Genetic Therapy; Glucagon-Like Peptide 1; Heparin; Humans; Male; Mice; Mice, Inbred C57BL; Rats, Sprague-Dawley; Rats, Zucker; Taurocholic Acid | 2017 |
Improvement of Glucose Metabolism Following Long-Term Taurocholic Acid Gavage in a Diabetic Rat Model.
Topics: Animals; Bile Acids and Salts; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diet, High-Fat; Disease Models, Animal; Glucose; Glucose Tolerance Test; Insulin; Insulin Resistance; Male; Rats; Rats, Sprague-Dawley; Taurocholic Acid | 2018 |
An integrated epigenomic analysis for type 2 diabetes susceptibility loci in monozygotic twins.
Topics: Biomarkers; Case-Control Studies; Caspases; CpG Islands; Diabetes Mellitus, Type 2; DNA Methylation; Epigenesis, Genetic; Epigenomics; Genetic Loci; Genetic Predisposition to Disease; Genome-Wide Association Study; Genome, Human; Humans; Insulin; Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 Protein; Neoplasm Proteins; Nerve Tissue Proteins; Promoter Regions, Genetic; Protein Kinase C beta; Receptors, G-Protein-Coupled; Taurocholic Acid; Twins, Monozygotic | 2014 |
Rectal taurocholate increases L cell and insulin secretion, and decreases blood glucose and food intake in obese type 2 diabetic volunteers.
Topics: Adult; Blood Glucose; Body Mass Index; Cholagogues and Choleretics; Diabetes Mellitus, Type 2; Eating; Enteroendocrine Cells; Glucagon-Like Peptide 1; Humans; Insulin; Insulin Secretion; Male; Middle Aged; Obesity; Peptide YY; Rectum; Taurocholic Acid; United Arab Emirates | 2012 |
Effects of rectal administration of taurocholic acid on glucagon-like peptide-1 and peptide YY secretion in healthy humans.
Topics: Administration, Rectal; Adult; Appetite Regulation; Blood Glucose; Body Mass Index; Cholagogues and Choleretics; Diabetes Mellitus, Type 2; Enema; Glucagon-Like Peptide 1; Humans; Male; Obesity; Peptide YY; Taurocholic Acid; Treatment Outcome | 2013 |